GLP-1 Coverage: Making Informed Decisions in a High-Cost Drug Market

GLP-1 medications have become a major consideration for employers managing pharmacy benefit costs. While these medications play an important role in treating certain conditions, expanded use for weight management has introduced new financial challenges for employer-sponsored health plans.

Today, employers must consider whether GLP-1 coverage aligns with their plan’s financial priorities, benefit philosophy, and long-term goals. A thoughtful GLP-1 strategy starts with understanding the cost implications of coverage, evaluating available options, and making deliberate decisions based on each employer's priorities.

Coverage is a plan-design decision

GLP-1 coverage is not a one-size-fits-all decision. Employers must consider factors that are unique to their goals and member population, such as covered clinical indications, potential utilization, and the financial impact on their pharmacy benefit.

It’s important to note that coverage for diabetes and other medically appropriate indications should be evaluated separately from coverage for weight management. Each has distinct considerations, and employers should understand the implications of their decisions across indications.

For employers concerned about rising pharmacy costs, excluding coverage for weight-loss medications may be the most appropriate approach. Others may choose to offer coverage based on their benefit objectives and financial tolerance.

The important thing is to make an informed decision based on your plan goals rather than assume coverage is necessary or that the potential long-term benefits will offset the cost of treatment.

If you choose coverage, establish a strategy

For employers that elect to cover GLP-1 medications for weight management, these considerations can help inform how that coverage is structured.

Define clinical criteria. Establish evidence-based, clinically appropriate coverage requirements that align with the plan's objectives. Depending on the strategy, these criteria might include clinical eligibility, relevant comorbidities, or other appropriate factors.

Understand the financial exposure. Evaluate expected utilization, medication costs, and the potential impact on overall pharmacy spend. Utilization management may help define appropriate use, but it does not eliminate the underlying cost of covering these medications.

Evaluate available sourcing options. Depending on the medication, eligibility requirements, and applicable regulations, employers may be able to take advantage of alternative models, such as personal importation programs or direct-to-employer pharmacy options.

Each model has different pricing, access, operational, and regulatory considerations. Availability and suitability should be assessed for the specific medication and employer group.

Set clear expectations. Employers should understand their coverage strategy design and its goals, which costs it addresses, and how to measure success. Remember that clinical outcomes, member access, and financial performance are distinct measures and may not always move in the same direction.

Evaluate the strategy as the market evolves

As the GLP-1 market continues to change, employers should periodically reassess their decisions to determine whether their approach remains aligned with their financial and benefit objectives.

That doesn't necessarily mean expanding coverage as new options emerge. Instead, it means understanding the available choices and being prepared to adjust the plan's approach when the clinical, financial, or regulatory landscape changes.

Some employers may maintain an exclusion for weight-loss medications. Others may refine existing coverage or evaluate alternative sourcing arrangements.

There is no universal answer, and coverage decisions should be based on the employer's specific goals rather than assumptions about future savings.

The opportunity for brokers and employers

GLP-1s present an opportunity for employers and their benefits advisors to take a closer look at pharmacy benefit design, cost exposure, and available management strategies.

Rather than approaching coverage as an automatic yes-or-no decision, employers should evaluate the implications of each option and determine which approach best fits their priorities.

For employers that choose coverage, a well-defined strategy can help establish clearer expectations and identify opportunities to manage costs. For employers that do not, a deliberate coverage exclusion can be equally valid when aligned with their benefit objectives.

Make an informed GLP-1 coverage decision

GLP-1 medications are an important and evolving part of the healthcare landscape, but their clinical worth does not automatically translate into financial value for every employer-sponsored plan.

The right strategy starts with understanding the tradeoffs, evaluating the available options, and making decisions that align with the employer's specific priorities.

VeracityRx helps employers evaluate pharmacy benefit strategies, understand cost-management opportunities, and make informed decisions about GLP-1 coverage. Whether your plan is evaluating coverage or looking for ways to manage the cost of existing benefits, our team can help you explore your options.

Is your clients’ GLP-1 coverage still aligned with their plan goals? Use these considerations at your next renewal conversation, and if you’d like help weighing the options, we’d love to show you how VeracityRx can support a more deliberate approach.